A detailed history of Black Rock Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 23,394,984 shares of PACB stock, worth $32.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,394,984
Previous 24,642,666 5.06%
Holding current value
$32.1 Million
Previous $242 Million 63.71%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$3.52 - $9.59 $4.39 Million - $12 Million
-1,247,682 Reduced 5.06%
23,394,984 $87.7 Million
Q4 2023

Feb 13, 2024

BUY
$5.97 - $10.36 $11.7 Million - $20.4 Million
1,966,160 Added 8.67%
24,642,666 $242 Million
Q3 2023

Nov 13, 2023

BUY
$8.23 - $13.93 $15.3 Million - $25.8 Million
1,853,603 Added 8.9%
22,676,506 $189 Million
Q2 2023

Aug 11, 2023

BUY
$9.97 - $14.05 $6.19 Million - $8.73 Million
621,003 Added 3.07%
20,822,903 $277 Million
Q1 2023

May 12, 2023

BUY
$7.94 - $12.02 $13.2 Million - $20 Million
1,666,520 Added 8.99%
20,201,900 $234 Million
Q4 2022

Feb 13, 2023

BUY
$5.67 - $11.2 $3.55 Million - $7.02 Million
626,824 Added 3.5%
18,535,380 $152 Million
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $1.86 Million - $4.05 Million
-473,105 Reduced 2.57%
17,908,556 $104 Million
Q2 2022

Aug 12, 2022

BUY
$4.02 - $10.43 $7.12 Million - $18.5 Million
1,772,308 Added 10.67%
18,381,661 $81.2 Million
Q1 2022

May 12, 2022

BUY
$8.43 - $20.9 $338,118 - $838,278
40,109 Added 0.24%
16,609,353 $151 Million
Q4 2021

Feb 10, 2022

BUY
$19.26 - $30.08 $8.4 Million - $13.1 Million
436,273 Added 2.7%
16,569,244 $339 Million
Q3 2021

Nov 09, 2021

SELL
$24.86 - $35.02 $1.4 Million - $1.98 Million
-56,461 Reduced 0.35%
16,132,971 $412 Million
Q2 2021

Aug 11, 2021

BUY
$22.3 - $36.02 $361 Million - $583 Million
16,189,432 New
16,189,432 $566 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $308M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.